|
|
H2008/19032/114
|
XICARD 6.25 MG TABLETS
|
CARVEDILOL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD10433/23859
|
XIFAXAN 550 MG TABLETS
|
RIFAXIMIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2011/21708/192
|
XIFIX-200
|
CEFIXIME TRIHYDRATE USP. EQ. TO ANHYDROUS CEFIXIME
|
NATIONAL PHARMACY LTD
|
Registered
|
Details →
|
|
|
H2017/CTD4129/224
|
XIFIX-400
|
CEFIXIME TRIHYDRATE USP. EQ. TO ANHYDROUS CEFIXIME
|
NATIONAL PHARMACY LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9660/22009
|
XIGA-MET 5/1000 TABLET
|
DAPAGLIFLOZIN (PROPANEDIOL MONOHYDRATE) & METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9567/21989
|
XIGA-MET 5/850 TABLET
|
DAPAGLIFLOZIN (PROPANEDIOL MONOHYDRATE) & METFORMIN HCL
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2022/CTD9059/20183
|
XIGDUO XR 10 MG/1000 MG, EXTENDED RELEASE TABLETS
|
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
|
ASTRAZENECA PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD8460/16718
|
XIGDUO XR 5 MG/1000 MG, EXTENDED RELEASE TABLETS
|
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
|
ASTRAZENECA PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2025/CTD9163/18775
|
XILICA 150MG CAPSULE
|
PREGABALIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2025/CTD10005/18768
|
XILICA 50MG CAPSULE
|
PREGABLIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2025/CTD9162/18771
|
XILICA 75MG CAPSULE
|
PREGABALIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
19954
|
XIMACEF 100 ORAL SUSPENSION
|
CEFIXIME
|
GOODMAN AGENCIES LTD
|
Registered
|
Details →
|
|
|
19955
|
XIMACEF 400MG CAPSULE
|
CEFIXIME
|
GOODMAN AGENCIES LTD
|
Registered
|
Details →
|
|
|
15796
|
XIME 200 TABLETS
|
CEFIXIME
|
DAWA LTD
|
Registered
|
Details →
|
|
|
22256
|
XIME OD
|
CEFIXIME
|
DAWA LTD
|
Registered
|
Details →
|
|
|
15791
|
XIME SUSPENSION
|
CEFIXIME
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2014/CTD2178/421
|
XIMECOR 500MG TABLETS
|
CEFUROXIME AXETIL TABLETS BP 500MG
|
SIGNATURE HEALTHCARE LTD
|
Registered
|
Details →
|
|
|
18471
|
XIMEPROX
|
CEFPODOXIME
|
RADIANCE PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD5871/1847ER
|
XIMEPROX 200 TABLET
|
CEFPODOXIME PROXETIL
|
RADIANCE PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2020/CTD5872/1846ER
|
XIMEPROX DS POWDER FOR SUSPENSION
|
CEFPODOXIME PROXETIL
|
RADIANCE PHARMACEUTICALS LTD
|
Registered
|
Details →
|